SenzaGen Q1: Quarterly sales impacted by challenging market climate - Redeye

Redeye provides an update following SenzaGen’s Q1 2025 report. The quarterly figures came in a bit below our expectations; however, we argue that the long-term outlook and our investment case are intact. Based on the report, we make some downward changes to our sales estimates, rendering an updated fair value range.

Länk till analysen i sin helhet: https://www.redeye.se/research/1108638/senzagen-q1-quarterly-sales-impacted-by-challenging-market-climate?utm_source=finwire&utm_medium=RSS